OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
The OncLive Insider app is live!CME Opportunities
Specialty
View MoreBreast CancerLung CancerGastrointestinal CancerGenitourinary CancersOvarian CancerProstate CancerMelanoma & Skin CancerMCLMPNCAR T-cell TherapyChronic Lymphocytic LeukemiaGynecologic OncologyHematologic OncologyImmuno-OncologyMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
PartnersPublications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker ConsortiumSubscribe
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2025 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • The OncLive Insider app is live!
  • CME Opportunities
SpecialtySee All >
  • Breast Cancer
  • Lung Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Ovarian Cancer
  • Prostate Cancer
  • Melanoma & Skin Cancer
  • MCL
  • MPN
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gynecologic Oncology
  • Hematologic Oncology
  • Immuno-Oncology
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Revolutionary Advances for Treating Urothelial Carcinoma

EP. 1: Revolutionary Advances for Treating Urothelial Carcinoma

April 22nd 2017

EP. 2: Bladder Cancer: Paradigm Changing Advances in Treatment

April 22nd 2017

EP. 3: Durvalumab FDA Approval for Bladder Cancer

April 22nd 2017

EP. 4: Historic Perspective on Bladder Cancer Treatment

April 22nd 2017

EP. 5: Frontline Atezolizumab for Advanced Bladder Cancer

April 22nd 2017

EP. 6: FDA Approval of Durvalumab for Bladder Cancer

April 22nd 2017

EP. 7: Treatment of Bladder Cancer-Immune Checkpoint Inhibitors

April 22nd 2017

EP. 8: FDA Approval of Durvalumab for Advanced Bladder Cancer

April 22nd 2017

EP. 9: Promising Treatment Options for Advanced Bladder Cancer

April 22nd 2017

EP. 10: Immune Checkpoint Inhibitors for Advanced Bladder Cancer

April 22nd 2017

EP. 11: Durvalumab for Treatment of Advanced Bladder Cancer

April 22nd 2017

EP. 12: Future Treatment Options for Advanced Bladder Cancer

April 22nd 2017

EP. 13: Use of Immune Checkpoint Inhibitors for Bladder Cancer

April 22nd 2017

EP. 14: Highlights of Durvalumab for Advanced Bladder Cancer

April 22nd 2017

EP. 15: Combination Therapies for Advanced Bladder Cancer

April 22nd 2017